In recent years, the concept of "cardiometabolic risk" is increasingly used in clinical practice. One of the most common diseases is non-alcoholic fatty liver disease (NAFLD) - a chronic liver disease that is considered as a component of some diseases associated with insulin resistance. The development of NAFLD on the background of comorbid pathology is closely associated with an increase in the degree of cardiometabolic risk, which can determine...